NervGen Pharma Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 09, 2023 at 08:24 am EDT
NervGen Pharma Corp. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was CAD 4.76 million compared to CAD 6.32 million a year ago. Basic loss per share from continuing operations was CAD 0.08 compared to CAD 0.13 a year ago.
For the six months, net loss was CAD 9.47 million compared to CAD 11.29 million a year ago. Basic loss per share from continuing operations was CAD 0.16 compared to CAD 0.24 a year ago.